{"nctId":"NCT04050865","briefTitle":"A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis","startDateStruct":{"date":"2019-08-05","type":"ACTUAL"},"conditions":["Allergic Conjunctivitis"],"count":96,"armGroups":[{"label":"OTX-DP","type":"EXPERIMENTAL","interventionNames":["Drug: Dexamethasone, 0.4mg"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Device: Placebo plug with no drug"]}],"interventions":[{"name":"Dexamethasone, 0.4mg","otherNames":["OTX-DP"]},{"name":"Placebo plug with no drug","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has a positive history of ocular allergies and a positive skin test reaction to a perennial allergen and a seasonal allergen\n* Has a positive bilateral CAC reaction to a perennial allergen within minutes of instillation\n\nExclusion Criteria:\n\n* History of refractive surgery (including LASIK procedures) within the past 2 years\n* History of retinal detachment, diabetic retinopathy, or active retinal disease\n* Presence of an active ocular infection or positive history of an ocular herpetic infection at any visit\n* History of IOP increase as a result of steroid treatment\n* A female who is currently pregnant, planning a pregnancy, or lactating","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ocular Itching Post-CAC (Conjunctival Allergen Challenge) at Visit 6 (7 Days Post-insertion)","description":"Modified CAC model (Ora, Andover, MA); Grade 0-4, allowing half unit Increments; 0 = None 0.5 = An intermittent tickle sensation possibly localized in the corner of the eye 1.0 = An intermittent tickle sensation involving more than just the corner of the eye 1.5 = An intermittent all-over tickling sensation 2.0 = A mild continuous itch (can be localized) without desire to rub 2.5 = A moderate, diffuse continuous itch with desire to rub 3.0 = A severe itch with desire to rub 3.5 = A severe itch improved with minimal rubbing 4.0 = An incapacitating itch with an irresistible urge to rub 0.5 unit increments ARE allowed","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.80","spread":null},{"groupId":"OG001","value":"2.69","spread":null}]}]}]},{"type":"PRIMARY","title":"Ocular Itching Post-CAC (Conjunctival Allergan Challenge) at Visit 6 (7 Days Post-insertion)","description":"Modified CAC model (Ora, Andover, MA); Grade 0-4, allowing half unit increments;\n\n0 = None 0.5 = An intermittent tickle sensation possibly localized in the corner of the eye 1.0 = An intermittent tickle sensation involving more than just the corner of the eye 1.5 = An intermittent all-over tickling sensation 2.0 = A mild continuous itch (can be localized) without desire to rub 2.5 = A moderate, diffuse continuous itch with desire to rub 3.0 = A severe itch with desire to rub 3.5 = A severe itch improved with minimal rubbing 4.0 = An incapacitating itch with an irresistible urge to rub 0.5 unit increments ARE allowed","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.73","spread":null},{"groupId":"OG001","value":"2.72","spread":null}]}]}]},{"type":"PRIMARY","title":"Ocular Itching Post-CAC (Conjunctival Allergan Challenge) at Visit 6 (7 Days Post-insertion)","description":"Modified CAC model (Ora, Andover, MA); Grade 0-4, allowing half unit increments;\n\n0 = None 0.5 = An intermittent tickle sensation possibly localized in the corner of the eye 1.0 = An intermittent tickle sensation involving more than just the corner of the eye 1.5 = An intermittent all-over tickling sensation 2.0 = A mild continuous itch (can be localized) without desire to rub 2.5 = A moderate, diffuse continuous itch with desire to rub 3.0 = A severe itch with desire to rub 3.5 = A severe itch improved with minimal rubbing 4.0 = An incapacitating itch with an irresistible urge to rub 0.5 unit increments ARE allowed","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":null},{"groupId":"OG001","value":"2.71","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":48},"commonTop":["Treatment Emergent Adverse Events"]}}}